Prostaglandin E2 reinforces the activation of Ras signal pathway in lung adenocarcinoma cells via EP3

被引:57
作者
Yano, T
Zissel, G
Muller-Qernheim, J
Shin, SJ
Satoh, H
Ichikawa, T
机构
[1] Natl Inst Hlth & Nutr, Dept Food Sci Res Hlth, Shinjuku Ku, Tokyo 1628636, Japan
[2] Hosp Med, Res Ctr Borstel, D-23845 Borstel, Germany
关键词
prostaglandin E; Ras; lung adenocarcinoma; alveolar type II cell; cAMP; EP3;
D O I
10.1016/S0014-5793(02)02689-3
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prostaglandin E-2 (PGE(2))-dependent effects on various cell responses are regulated by respective PGE(2) receptors (EP1, EP2, EP3, EP4) expressing in target cells. Alveolar type H cell (a main progenitor cell of lung adenocarcinoma) expressed only EP4, while human lung adenocarcinoma cells (A549) expressed EP3 as well as EP4. An antagonistic effect of EP3 against EP4 through the modulation of cyclic AATP level is required for PGE(2)-mediated activation of Ras signal pathway in A549 cells. These results suggest that the expression of EP3 may be a critical factor for the PGE(2)-mediated activation of Ras signal pathway in A549 cells. (C) 2002 Published by Elsevier Science B.V. on behalf of the Federation of European Biochemical Societies.
引用
收藏
页码:154 / 158
页数:5
相关论文
共 21 条
[11]   Cancer statistics, 1998 [J].
Landis, SH ;
Murray, T ;
Bolden, S ;
Wingo, PA .
CA-A CANCER JOURNAL FOR CLINICIANS, 1998, 48 (01) :6-+
[12]  
MITSUDOMI T, 1991, CANCER RES, V51, P4999
[13]   ALTERNATIVE SPLICING OF C-TERMINAL TAIL OF PROSTAGLANDIN-E RECEPTOR SUBTYPE-EP3 DETERMINES G-PROTEIN SPECIFICITY [J].
NAMBA, T ;
SUGIMOTO, Y ;
NEGISHI, M ;
IRIE, A ;
USHIKUBI, F ;
KAKIZUKA, A ;
ITO, S ;
ICHIKAWA, A ;
NARUMIYA, S .
NATURE, 1993, 365 (6442) :166-170
[14]   Prostanoid receptors: Structures, properties, and functions [J].
Narumiya, S ;
Sugimoto, Y ;
Ushikubi, F .
PHYSIOLOGICAL REVIEWS, 1999, 79 (04) :1193-1226
[15]  
NEGISHI M, 1989, J BIOL CHEM, V264, P3916
[16]   Suppression of intestinal polyposis in Apc(Delta 716) knockout mice by inhibition of cyclooxygenase 2 (COX-2) [J].
Oshima, M ;
Dinchuk, JE ;
Kargman, SL ;
Oshima, H ;
Hancock, B ;
Kwong, E ;
Trzaskos, JM ;
Evans, JF ;
Taketo, MM .
CELL, 1996, 87 (05) :803-809
[17]   Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo [J].
Sebolt-Leopold, JS ;
Dudley, DT ;
Herrera, R ;
Van Becelaere, K ;
Wiland, A ;
Gowan, RC ;
Tecle, H ;
Barrett, SD ;
Bridges, A ;
Przybranowski, S ;
Leopold, WR ;
Saltiel, AR .
NATURE MEDICINE, 1999, 5 (07) :810-816
[18]   Biphasic actions of prostaglandin E2 on the renal afferent arteriole -: Role of EP3 and EP4 receptors [J].
Tang, LL ;
Loutzenhiser, K ;
Loutzenhiser, R .
CIRCULATION RESEARCH, 2000, 86 (06) :663-670
[19]  
Watanabe K, 1999, CANCER RES, V59, P5093
[20]   Vitamin E inhibits cell proliferation and the activation of extracellular signal-regulated kinase during the promotion phase of lung tumorigenesis irrespective of antioxidative effect [J].
Yano, T ;
Yajima, S ;
Hagiwara, K ;
Kumadaki, I ;
Yano, Y ;
Otani, S ;
Uchida, M ;
Ichikawa, T .
CARCINOGENESIS, 2000, 21 (11) :2129-2133